Latest Blogs

Jun 17, 2021
In his new series, Dr. Dawood FIndakly provides insights to help determine future medical careers and subspecialty selection by utilizing concepts he learned throughout his career. 
Jun 10, 2021
According to Dr. Aakash Desai and Dr. Turab Mohammed, the pandemic has emphasized one of the most challenging yet quintessential skills needed for a health care provider: the ability to break bad news compassionately to families.
Jun 04, 2021
Dr. Shaalan Beg and I discuss the difficulties of navigating situations in which our duty to be honest to the person we treat abuts another's cultural or social norms.
Jun 03, 2021
Being recognized based on my social media presence can be a little creepy, but there are certainly really good reasons for health care professionals to be active on these platforms.
Subscribe to this column

Daniel F. Hayes, MD, FACP, FASCO, BA

Daniel F. Hayes, MD, FACP, FASCO, is a Professor of Internal Medicine, the Stuart B. Padnos Professor in Breast Cancer, and the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center. An ASCO member since 1986, Dr. Hayes has served the Society in numerous volunteer capacities, including as 2016-2017 ASCO President. He is involved in several ASCO Expert Panels related to breast cancer. He served on the ASCO Board of Directors from 2011-2014, on the Conquer Cancer Foundation Grants Selection Committee, as Chair of the Scientific Program Committee, and on the Journal of Clinical Oncology Editorial Board. In 2007, he was presented with ASCO’s Gianni Bonadonna Breast Cancer Award and Lecture; in 2013, he was elected as a Fellow of ASCO (FASCO). Follow Dr. Hayes on Twitter @hoosierdfh.

Apr 07, 2017
We’re making progress in better understanding, and communicating, the many issues surrounding adverse events, although not as fast as we’d like. In the long run, our patients will benefit from all of these initiatives.
Mar 31, 2017
Sustaining this progress described in this report will be determined in large part by the level of federal investment in our nation's biomedical research enterprise.
Mar 16, 2017
ASCO soundly opposes President Trump’s budget outline, which would cut $6 billion from the National Institutes of Health.
Mar 07, 2017
I am pleased to share the news that ASCO volunteers, staff, and collaborators are already making progress on major expansions to ASCO's programs to address global oncology priorities.
Jan 05, 2017
Do you belong to your ASCO State/Regional Affiliate? If not, you should! Do you take advantage of all they have to offer? If not, you should! You, and more importantly your patients, will benefit enormously.
Dec 22, 2016
The advent of rapid and relatively affordable high-throughput molecular analyses has permitted the development of a bewildering next generation of new cancer diagnostic tests that are being introduced into clinical care using our grandparents’ regulatory structure.

Pages